From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.
Signals brief
ExitOdds reads Nuntius Therapeutics's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.
Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.